跳至主要内容
临床试验/NCT02465255
NCT02465255已完成3 期

Sublingual Analgesia for Acute Abdominal Pain in Children. Ketorolac Versus Tramadol Versus Paracetamol, a Randomized, Control Trial

IRCCS Burlo Garofolo1 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2015年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
210
试验地点
1
主要终点
Pain Score

研究概览

简要总结

Acute abdominal pain is a frequent symptom in children admitted to the emergency department . In the past the fear of masking a surgical condition has justified withholding analgesia in patients with acute abdominal pain. By the 2000s, some clinical trials established that opioid analgesia before surgical consultation does not affect diagnostic accuracy or outcome in children with acute abdominal pain. Despite this, acute abdominal pain is still undertreated in this setting. Published paediatric trials studied the effect of opioid analgesia administered by parenteral route or by mouth. To the best of our knowledge no study investigated the effectiveness of sublingual analgesia.

The purpose of this randomized controlled trial is to assess the effectiveness of three different drugs (ketorolac, tramadol, paracetamol), administered by the sublingual route, in children complaining of acute abdominal pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
4 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 4 to 18 years
  • Emergency department admission for moderate to severe acute abdominal pain (VAS/NRS score >=6)
  • Informed consent signed by parents or legal guardians

排除标准

  • Known allergy or sensitivity to nonsteroidal anti-inflammatory drug, opioids or acetaminophen
  • Use of analgesic drugs in the 8 hours before
  • Clinical suspicion of abdominal pain due to fecal stasis
  • Moderate or severe dehydration (weight loss of more than 5%)
  • Known nephropathy, liver disease, metabolic or neurologic disease
  • Thrombocytopenia or history of bleeding disease

研究组 & 干预措施

Ketorolac

Experimental

Ketorolac 0.5 mg/kg administrated by sublingual route

干预措施: Ketorolac (Drug)

Tramadol

Active Comparator

Tramadol 2.0 mg/kg administrated by sublingual route

干预措施: Tramadol (Drug)

Acetaminophen (paracetamol)

Active Comparator

Acetaminophen (paracetamol) 20.0 mg/kg administrated by sublingual route

干预措施: Acetaminophen (Drug)

结局指标

主要结局

Pain Score

时间窗: 120 minutes after drug administration

Pain score evaluated with visual analogical scale (VAS) or Numeric Rating Scale (NRS) depending on child age

次要结局

  • Pain Score(60 minutes after drug administration)
  • Adverse events(up to 180 hours after the drug administration)
  • Missed or delayed diagnosis of acute appendicitis or other abdominal pathology (i.e., pancreatitis)(48 hours after drug administration)

研究者

发起方
IRCCS Burlo Garofolo
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luca Ronfani

MD, PhD

IRCCS Burlo Garofolo

研究点 (1)

Loading locations...

相似试验